Skip to content

comparing the clinical effect, safety and cost for the outpatient and inpatient total knee arthroplasty: a randomized controlled trial

comparing the clinical effect, safety and cost for the outpatient and inpatient total knee arthroplasty: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017187
Enrollment
Unknown
Registered
2018-07-17
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TKA

Interventions

A:outpatient TKA
B:inpatient TKA

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Primary unilateral total knee artropasty; 2. Patients with Knee osteoarthritis; 3. Aged from 18-65 years with no limitation of gender; 4. Patients who volunteered to participate in clinical trials and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients combined with acute trauma, tumor, severe osteoporosis, other autoimmune diseases and severe muscle contracture deformity around hip/knee; 2. Previous history of neuro-vascular injury, vasculitis and diabetic foot etc; 3. Related thrombosis history, such as pulmonary embolism, thrombosis and deep vein thrombosis in recent three months; 4. Coagulation disorders, bleeding tendency or intraoperative active bleeding; 5. Sever comorbidities in brain cardiovascular system, liver (ALT or AST >2 high limitation of normal value), kidney (BUN >1.5 high limitation of normal value or Cr> 1.5 high limitation of normal value), endocrine, nerve, hematopoietic system or consciousness disorders; 6. Pregnancy or breast-feeding; 7. Allergy to the test drug and human serum albumin, severe allergies, drug or alcohol dependence; 8. Participate in other clinical trials in recent three months; 9. The surgeons believe the patients not suitable for this clinical trial.

Design outcomes

Primary

MeasureTime frame
Clinical effect;cost;

Countries

China

Contacts

Public ContactZhou Zong-ke

West China Hospital, Sichuan University

zongke@126.com+86 18980601028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026